Element is thrilled to announce the launch of its groundbreaking Rapid Response Pharmaceutical Testing Service from its Manchester Life Sciences laboratory. This innovative offering will support the pharmaceutical industry by providing expedited and comprehensive testing solutions for customers worldwide to meet the demands of today's fast-paced market.

In response to the growing need for timely and reliable testing services in the pharmaceutical sector, Element has developed a state-of-the-art facility that streamlines the testing process without compromising accuracy or quality. Leveraging advanced technologies and industry expertise, Element's Rapid Response Pharmaceutical Testing Service delivers results with unprecedented speed and efficiency.

The service covers a wide range of testing requirements, including but not limited to:

  • Active pharmaceutical ingredients (API) & final drug products
  • Delivery devices & packaging
  • Biopharmaceutical single-use systems (SUS)
  • Extractables and leachables
  • Degradation production
  • Production process-related impurities
  • Residual solvents USP <467>
  • Extrinsic contamination
  • Elemental impurities – ICH Q3D
    Element's team of experienced scientists and technicians work tirelessly to ensure that all testing procedures adhere to the highest quality and compliance standards. The service will aid customers by quickly reacting to and resolving problems arising during the pharmaceutical and medical device development processes. It will support resolving complex issues and requirements linked to regulatory submissions. With a commitment to excellence and customer satisfaction, Element guarantees accurate and reliable results delivered in record time.

    "Our Rapid Response Pharmaceutical Testing Service represents a significant advancement for Element in supporting pharmaceutical and Medical Device testing and Development," said Iain Gibb, General Manager at Element’s Manchester, UK lab. "We understand the critical importance of timely and precise testing in the pharmaceutical industry, and our new service is designed to address these needs head-on. Whether our customers require routine testing or urgent analysis, they can trust Element to deliver exceptional results with unmatched speed and efficiency."

    Furthermore, Element's Rapid Response team’s commitment to innovation and excellence is exemplified in a recent case study where our service identified an adhesive leachable in a medical infusion bag, and a suitable alternative was suggested for the customer to take the product to market safely. This case study underscores Element's capability to handle complex pharmaceutical testing challenges and to deliver insightful and actionable results to its customers, further solidifying its position as a trusted partner in the pharmaceutical industry.

    Element's Rapid Response Pharmaceutical Testing Service is now available to pharmaceutical companies worldwide.